Harvard University scientists have made major progress in dealing with a long-standing hurdle in treating diabetic patients.They are now working on “mini-stomachs” with insulin-producing cells as a diabetes treatment.he pyloric stomach also has the advantage of containing stem cells that, once reprogrammed, can replenish the insulin-producing cell population.
People with diabetes have high blood sugar because their pancreatic beta cells (which store and release insulin) are not producing enough insulin. In type 1 diabetes (“juvenile diabetes”), the beta cells are even destroyed. In most cases, physicians treat type 1 diabetes with insulin injections, but people with complications may require pancreas implants or pancreatic islets from another person to replace those defective beta cells.